RxDoctor Payments DataLook up a doctor →

James Beegan, MD

Physical Medicine & Rehabilitation · Centerville, OHNPI 1508831603

Payments from drug & device makers

$96,195in general payments, 2019–2025

Across 644 payments — averaging $149.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$75K
  • Ipsen Pharma SAS$12K
  • UCB, Inc.$688
  • Amgen$659
  • Novartis$549
  • Lilly USA, LLC$527
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)131$75,192
Ipsen Pharma SAS7$12,129
UCB, Inc.42$688
Amgen45$659
Novartis41$549
Lilly USA, LLC42$527
SK Life Science, Inc.22$480
AstraZeneca(2 entities)22$424
Biogen20$402
Neurocrine Biosciences, Inc.17$358
Acorda Therapeutics, Inc21$348
Lundbeck LLC18$345
Acadia Pharmaceuticals Inc17$333
EMD Serono, Inc.16$298
Pfizer13$233
Genentech USA, Inc.9$182
Amneal Pharmaceuticals LLC9$167
Argenx US, Inc.7$162
Jazz Pharmaceuticals Inc.8$161
Biohaven Pharmaceutical Holding Company Ltd.10$147
Neurelis, Inc.8$142
Ipsen Biopharmaceuticals, Inc9$131
Takeda Pharmaceuticals U.S.A., Inc.5$129
Eisai Inc.6$125
MDD US Operations, LLC7$123
Merz Pharmaceuticals, LLC6$123
Biohaven Pharmaceuticals, Inc.5$110
Alnylam Pharmaceuticals Inc.5$109
Insightec,inc2$106
GE HealthCare3$95
Sunovion Pharmaceuticals Inc.5$88
Axsome Therapeutics, Inc.4$83
Octapharma USA, Inc.5$81
Supernus Pharmaceuticals, Inc.4$71
Harmony Biosciences LLC3$69
Sumitomo Pharma America, Inc.3$62
Greenwich Biosciences, Inc.4$61
CSL Behring4$57
Avanir Pharmaceuticals, Inc.4$55
Adamas Pharmaceuticals, Inc.4$55
Grifols USA, LLC3$51
Johnson & Johnson2$45
TG Therapeutics, Inc.2$38
Aprecia Pharmaceuticals, LLC2$34
Sanofi2$29
Teva Pharmaceuticals USA, Inc.2$28
Revance Therapeutics, Inc.1$26
Catalyst Pharmaceuticals, Inc.1$25
Philips North America LLC1$22
Scilex Pharmaceuticals Inc.1$21
Otsuka America Pharmaceutical, Inc.1$21
Banner Life Sciences, LLC1$20
Merz North America, Inc.1$18
Upsher-smith Laboratories LLC1$18
Amylyx Pharmaceuticals, Inc.1$18
Cala Health, Inc.1$17
Akcea Therapeutics, Inc.1$16
Aquestive Therapeutics, Inc.1$16
Kyowa Kirin, Inc.1$15
Currax Pharmaceuticals LLC1$15

How this compares

$96,195 in reported general payments places this provider in the 95th percentile of 332 physical medicine & rehabilitation providers in Ohio.

See all physical medicine & rehabilitation providers in Ohio →

Medicare billing

Part B allowed, 2024
$384,048
Medicare patients
312
Services billed
38,553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physical medicine & rehabilitation in Centerville

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →